Glycolysis Reprogramming in Idiopathic Pulmonary Fibrosis: Unveiling the Mystery of Lactate in the Lung
International Journal of Molecular Sciences · 25.12.2023 · 25 (1) · 315
DOI: 10.3390/ijms25010315 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.12.2023. Verfasst von Peishuo Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cell Differentiation and Regulation, Henan Center for Outstanding Overseas Scientists of Organ Fibrosis, Pingyuan Laboratory,…. Hauptthemen laut MEDLINE: Lactic Acid, Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Henan Province Science and Technology Project, Ministry of Science and Technology, State Innovation Base for Pulmonary Fibrosis.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease characterized by excessive deposition of fibrotic connective tissue in the lungs. Emerging evidence suggests that metabolic alterations, particularly glycolysis reprogramming, play a crucial role in the pathogenesis of IPF. Lactate, once considered a metabolic waste product, is now recognized as a signaling molecule involved in various cellular processes. In the context of IPF, lactate has been shown to promote fibroblast activation, myofibroblast differentiation, and extracellular matrix remodeling. Furthermore, lactate can modulate immune responses and contribute to the pro-inflammatory microenvironment observed in IPF. In addition, lactate has been implicated in the crosstalk between different cell types involved in IPF; it can influence cell–cell communication, cytokine production, and the activation of profibrotic signaling pathways. This review aims to summarize the current research progress on the role of glycolytic reprogramming and lactate in IPF and its potential implications to clarify the role of lactate in IPF and to provide a reference and direction for future research. In conclusion, elucidating the intricate interplay between lactate metabolism and fibrotic processes may lead to the development of innovative therapeutic strategies for IPF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Cell Differentiation and Regulation, Henan Center for Outstanding Overseas Scientists of Organ Fibrosis, Pingyuan Laboratory, College of Life Science, Henan Normal University, Xinxiang 453007, Ch…
ORCID-Profile: Peishuo Yan, Guoying Yu
Förderung
- Henan Province Science and Technology Project
- Ministry of Science and Technology
- State Innovation Base for Pulmonary Fibrosis
- He-nan Project of Science and Technology
- Xinxiang Major Project
- Outstanding Overseas Scientists of Organ Fibrosis Project
Zitieren
APA
Yan, P., Liu, J., Li, Z., Wang, J., Zhu, Z., Wang, L., & Yu, G. (2023). Glycolysis Reprogramming in Idiopathic Pulmonary Fibrosis: Unveiling the Mystery of Lactate in the Lung. International Journal of Molecular Sciences, 25(1), 315. https://doi.org/10.3390/ijms25010315
Vancouver
Yan P, Liu J, Li Z, Wang J, Zhu Z, Wang L, et al. Glycolysis Reprogramming in Idiopathic Pulmonary Fibrosis: Unveiling the Mystery of Lactate in the Lung. International Journal of Molecular Sciences. 2023;25(1):315. doi:10.3390/ijms25010315
BibTeX
@article{Yan2023,
author = {Yan, Peishuo and Liu, Jingyi and Li, Zhenwei and Wang, Jiawei and Zhu, Zhao and Wang, Lan and Yu, Guoying},
title = {Glycolysis Reprogramming in Idiopathic Pulmonary Fibrosis: Unveiling the Mystery of Lactate in the Lung},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {25},
number = {1},
pages = {315},
doi = {10.3390/ijms25010315}
}
EUVIMED